THE 16th NCGM IIDF Updates on AMR - Trends and Countermeasures for Antimicrobial-resistant Bacterial Infections, and New Antibiotics(SEPTEMBER 29, 2023)
PROGRAM
- "Initiatives of AMR Clinical Reference Center in Japan"
Dr. Nobuaki MATSUNAGA(Chief, Division of Clinical Epidemiology, AMR Clinical Reference Centre, NCGM) - "Current Situation & Challenges of Antimicrobial-Resistant Bacteria in Indonesia"
Dr. Anis Karuniawati, SpMK., Ph.D.(Lecturer, University of Indonesia, Indonesia; Chair of the Antimicrobial Resistance Control Committee, Indonesia) - "Current Situation & Challenges of Antimicrobial-Resistant Bacteria in Vietnam"
Dr. Vu Quoc Dat(Lecturer, Hanoi Medical University, Vietnam) - "Issues in Antimicrobial Susceptibility Test and Appropriate Test Methods"
Mr. Tsuyoshi SHIOZAWA(Manager, Applied Technology Laboratory, Research & Development Division, EIKEN CHEMICAL CO.,LTD.) - "AMR Pathogen Surveillance and Antimicrobial Resistant Bacterial Bank in Japan"
Dr. Motoyuki SUGAI(Director, Antimicrobial Resistance Research Center, National Institute of Infectious Diseases) - "Antimicrobial Therapy: Now and the Future"
Dr. Yohei DOI(Professor, Fujita Health University)
16th NCGM International Infectious Diseases Forum Flyer
THE 14th NCGM IIDF From Japan to overseas International Activities of Japanese Academia and Pharmaceuticals and Medical Devices(JUNE 17, 2022)
PROGRAM
- "International Joint Research for Countermeasures against Antimicrobial-Resistant (AMR) Bacteria and Promotion of Appropriate Use of Antibacterial Agents in Vietnam” by a Cooperation Project Industrial and Public Sectors"
Dr. Katsunori KANAZAWA(Officer, Infectious Diseases, Medical InformationSumitomo Pharma Co., Ltd.) - "A global ARO network to leverage academic clinical trials in Asia"
Ms. Miwa SONODA(Medical Science Liaison, Department of International Trials, Center for Clinical Sciences, NCGM) - "Prospects of Building a Sustainable Japan-Africa Clinical Trials Network"
Dr. Sifa MUCHANGA(Regional Manager/Africa, Department of International Trials, Center for Clinical Sciences, NCGM) - "Prospects for ARO’s Clinical Study Support Platform and NCGM International Infectious Diseases Forum"
Department of International Trials, Center for Clinical Sciences, NCGM
14th NCGM International Infectious Diseases Forum Flyer
THE 13th NCGM IIDF Pharmaceutical R&D through international cooperation in the field of SARS-COV-2 Infectious diseases (DECEMBER 13, 2021)
PROGRAM
- "International Medical Policy promoted by the Japanese government"
Dr. Yasuyuki SAHARA (Director General, Health Bureau, Ministry of Health, Labour and Welfare) - "Current status of COVID-19 in Southeast Asia and the need for new medicine and medical devices to combat the disease in THAILAND"
Prof. Dr. Prasit WATANAPA (Dean, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand) - "Current situation of COVID-19 in Indonesia"
Prof. Dr. Irawan YUSUF(President, Mochtar Riady Institute for Nanotechnology, Universitas Pelita Harapan, Banten, Indonesia) - "Covid-19 Situation in the Philippines Medicine and Medical Device Needs"
Dr. Eva Maria CUTIONGCO-DELA PAZ (Executive Director, National Institute of Health, University of the Philippines-Manila, the Republic of the Philippines) - "Combating Covid-19 in Vietnam"
Dr. Vu Quoc DAT (Lecturer of Department of Infectious Diseases, Hanoi Medical University, Vietnam) - "Activities and Challenges toward Regulatory Harmonization"
Mr. Daisuke KOGA (Division Director, Division of Planning and Management and Division of Asia II/Office of International Programs, Pharmaceuticals and Medical Devices Agency (PMDA)) - "JICA's contribution to biomedical research partnerships"
Mr. Ikuo TAKIZAWA (Senior Deputy Director General and Senior Director, Office of COVID-19 Response, Human Development Department, Japan International Cooperation Agency (JICA)) - "Expectations and roles for international collaborative clinical studies and trials in the field of SARS-COV-2 infectious diseases"
Dr. Tatsuo IIYAMA (Director of International Trials, Center of Clinical Sciences, National Center for Global Health and Medicine (NCGM))